Table 2 Modelled incidence (acute infections per 100,000) by age-group in the years 2000 and 2030

<1

5.1 (2.5–7.9)

1.8 (0.48–3.1)

1-4

24.4 (21.1–27.6)

2.1 (1.2–3.0)

5-9

43.1 (39.3–47.1)

2.8 (1.9–3.8)

10-14

29.9 (26.7–33.1)

2.4 (1.5–3.2)

15-19

13.0 (10.7–15.2)

1.8 (1.0–2.5)

20-24

4.8 ( 3.6–6.0)

1.5 (0.89–2.2)

25-29

4.7 (3.6–5.9)

1.6 (0.93–2.2)

30-34

4.8 (3.7–5.8)

1.6 (0.89–2.2)

35-39

8.5 (7.1–9.9)

1.7 (1.1–2.4)

40-44

5.5 (4.3–6.7)

1.6 (0.97–2.3)

45-49

4.8 (3.7–6.0)

1.6 (0.90–2.2)

50-54

3.5 (2.5–4.4)

1.5 (0.79–2.1)

55-59

2.3 (1.4–3.3)

1.4 (0.79–2.0)

60-64

2.8 (1.7–3.9)

1.4 (0.80–1.9)

65-69

3.4 (2.1–4.6)

1.1 (0.59–1.6)

70-74

2.3 (1.2–3.4)

0.88 (0.39–1.3)

75-79

1.8 (0.87–2.9)

0.72 (0.27–1.2)

80-84

1.9 (0.68–3.2)

0.50 (0.15–0.87)

85+

1.9 (0.56 –3.2)

0.34 (0.08–0.60)